Co-Designed Digital Education and Peer Support for Young and Middle-Aged Stroke Survivors
A Co-Designed Digital Education and Peer Support Intervention for Reducing Unmet Needs and Enhancing Recovery Among Young and Middle-Aged Stroke Survivors
Stroke survivors often experience persistent unmet needs during long-term recovery. Young and middle-aged stroke survivors may face additional challenges in balancing rehabilitation with work and family responsibilities. Although digital health interventions have the potential to improve access to education and self-management support, existing programs are often provider-driven, provide limited peer support, and have short follow-up periods.
This study aims to evaluate the effectiveness of a patient-centered digital education and peer support intervention co-designed with young and middle-aged stroke survivors. Participants will be randomly assigned to either the intervention group or the usual care group. The intervention will be delivered through LINE communities and Google collaborative platforms over a 12-month period. The primary outcome is unmet needs. Secondary outcomes include stroke self-efficacy, depressive symptoms, quality of life, activities of daily living, instrumental activities of daily living, and return-to-work status.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Stroke survivors require continuous support to develop healthy lifestyles and self-management behaviors after hospital discharge. However, young and middle-aged stroke survivors often have work and family responsibilities that limit participation in conventional face-to-face education programs. Digital health interventions may improve accessibility and flexibility; however, previous studies have primarily been healthcare provider-led, with limited patient involvement in intervention development, insufficient peer support, relatively short intervention periods, and limited assessment of psychosocial outcomes.
This study consists of two phases. During Phase I, young and middle-aged stroke survivors will participate in a co-design process to develop a patient-centered digital education and peer support intervention. Feedback from a pilot study will be used to refine the intervention before the randomized controlled trial.
During Phase II, eligible participants will be randomly assigned to either the intervention group or the usual care group. Participants in the intervention group will receive a 12-month digital education and peer support program delivered through LINE communities and Google collaborative platforms. The program includes digital educational materials, peer interaction, online meetings, and ongoing support from healthcare professionals. Participants in the control group will receive usual post-stroke care.
Outcome measures will be collected at baseline and at 1, 3, 6, and 12 months after enrollment. The primary outcome is unmet needs. Secondary outcomes include stroke self-efficacy, depressive symptoms, quality of life, activities of daily living, instrumental activities of daily living, and return-to-work status. Longitudinal changes between groups will be analyzed using generalized estimating equations (GEE).
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Wen-YU Kuo, PhD
- Numero di telefono: 3411 +886-3-2118999
- Email: wykuo@mail.cgust.edu.tw
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Aged 31 to 64 years.
- Diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) and physician diagnosis.
- Received treatment at the Stroke Center of Linkou Chang Gung Memorial Hospital.
- Conscious and able to communicate, including individuals with mild aphasia.
- Willing and able to provide informed consent.
Exclusion Criteria:
- End-stage cancer.
- Severe aphasia resulting in inability to communicate.
- Dependent in basic activities of daily living before the index stroke (Barthel Index <100), regardless of the underlying cause.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental
Participants will receive a 12-month patient-centered digital education and peer support program
|
A 12-month patient-centered digital education and peer support program delivered through LINE communities and Google collaborative platforms.
|
|
Comparatore attivo: Usual Care
Participants will receive usual post-stroke care, including routine follow-up and telephone contacts, without access to the digital education and peer support program.
|
Routine post-stroke care provided by the participating hospital, including standard discharge education and follow-up telephone contacts.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Unmet Needs
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Unmet Needs Questionnaire for young stroke survivors
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Self-Efficacy
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Chinese version of the Stroke Self-Efficacy Questionnaire
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
|
Depressive Symptoms
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Taiwanese Depression Questionnaire
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
|
WHOQOL-BREF Score
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Taiwan version of the WHOQOL-BREF.
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
|
Activities of Daily Living
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Barthel Index.
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
|
Instrumental Activities of Daily Living
Lasso di tempo: Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using the Lawton Instrumental Activities of Daily Living Scale.
|
Baseline, 1 month, 3 months, 6 months, and 12 months after enrollment
|
|
Return-to-Work Status
Lasso di tempo: 1 month, 3 months, 6 months, and 12 months after enrollment
|
Assessed using a structured return-to-work questionnaire developed for this study.
|
1 month, 3 months, 6 months, and 12 months after enrollment
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Wen-Yu Kuo, PhD, Chang Gung University of Science and Technology
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 202501542A3
- NSTC 115-2314-B-255-010-MY3 (Altro numero di sovvenzione/finanziamento: National Science and Technology Council (NSTC), Taiwan)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .